Zevra Therapeutics, Inc.
ZVRA
Jodie situation report
Zevra Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 14 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- ZVRA's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ZVRA's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ZVRA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
AQSTAquestive Therapeutics, Inc.partnerMay 13, 2026 ▾
“In March 2012, we entered into an agreement with Zevra (formerly KemPharm, Inc.) to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ZVRA is currently a Follower in the organic co-movement group Healthcare & Consumer Products. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ZVRA; it is not active in the latest market snapshot.